News
EXPO
80.60
+0.30%
0.24
Exponent Inc <EXPO.OQ> expected to post earnings of 47 cents a share - Earnings Preview
Exponent Inc expected to show a fall in quarterly revenue to $125.979 million from $128.71 million. The company is expected to post earnings of 47 cents a share for the period ending March 31 2024. Wall Street's median 12-month price target for Exponent Inc is $88.50.
Reuters · 1d ago
Some Confidence Is Lacking In Exponent, Inc.'s (NASDAQ:EXPO) P/E
Exponent, Inc.'s (NASDAQ:EXPO) price-to-earnings ratio of 40.1x is higher than the market. The company's earnings are expected to grow by 2.7% per year over the next three years. Analyst forecasts suggest Exponent's earnings will grow at a slower rate than the broader market. Exponent is trading at a high P/E compared to other companies in the US.
Simply Wall St · 1d ago
Exponent Inc: Other definitive proxy statementsOpen document
Press release · 2d ago
Weekly Report: what happened at EXPO last week (0415-0419)?
Weekly Report · 3d ago
Analysts See 11% Gains Ahead For The Holdings of IJK
NASDAQ · 04/16 10:36
Weekly Report: what happened at EXPO last week (0408-0412)?
Weekly Report · 04/15 09:11
Exponent to Announce First Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on April 25, 2024
Exponent, Inc. Will report First Quarter of fiscal year 2024 financial results for the period ended March 29, 2024 on April 25, 2024. The company will host a conference call and webcast to discuss the Company's business and financial results. The conference call will be held on Thursday, April 25.
Barchart · 04/09 17:15
Weekly Report: what happened at EXPO last week (0401-0405)?
Weekly Report · 04/08 09:12
Weekly Report: what happened at EXPO last week (0325-0329)?
Weekly Report · 04/01 09:12
Investors in Exponent (NASDAQ:EXPO) have seen favorable returns of 54% over the past five years
Exponent, Inc. (NASDAQ:EXPO) has a share price rise of 46% over five years, below the market return. The share price is down 17% in the last year. The company has seen compound earnings per share growth of 7.8% per year over the last five years. Exponent shareholders are down 16% for the year, but the market itself is up 29%.
Simply Wall St · 03/30 14:36
Franklin Covey (FC) Beats Q2 Earnings Estimates
NASDAQ · 03/27 21:15
Exponent Inc: Initial statement of beneficial ownership of securities
Press release · 03/25 21:01
Weekly Report: what happened at EXPO last week (0318-0322)?
Weekly Report · 03/25 09:11
Exponent Inc: Statement of changes in beneficial ownership of securities
Press release · 03/20 02:15
Weekly Report: what happened at EXPO last week (0311-0315)?
Weekly Report · 03/18 09:12
Dividend Champion, Contender, And Challenger Highlights: Week Of March 17
Seeking Alpha · 03/17 14:01
Exponent Inc: Statement of changes in beneficial ownership of securities
Press release · 03/16 02:21
Weekly Report: what happened at EXPO last week (0304-0308)?
Weekly Report · 03/11 09:11
Ex-Dividend Reminder: Exponent, Knight-Swift Transportation Holdings and ITT
NASDAQ · 03/05 14:59
Weekly Report: what happened at EXPO last week (0226-0301)?
Weekly Report · 03/04 09:11
More
Webull provides a variety of real-time EXPO stock news. You can receive the latest news about Exponent Inc through multiple platforms. This information may help you make smarter investment decisions.
About EXPO
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm. The Company serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. It provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project- by-project basis. The Company has two segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment is a service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.